0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 41-60 of 496 Articles
Editor's Note | 
Joseph S. Ross, MD, MHS
JAMA Intern Med. 2014;174(8):1290. doi:10.1001/jamainternmed.2014.1862.

Invited Commentary | 
Beatrice Alexandra Golomb, MD, PhD
JAMA Intern Med. 2014;174(8):1270-1272. doi:10.1001/jamainternmed.2013.14543.

Original Investigation | 
Kirsten E. Austad, MD; Jerry Avorn, MD; Jessica M. Franklin, PhD; et al.
JAMA Intern Med. 2014;174(8):1283-1290. doi:10.1001/jamainternmed.2014.2202.
Includes: Supplemental Content

Original Investigation | 
David S. H. Lee, PharmD, PhD; Sheila Markwardt, BS; Leah Goeres, PharmD; et al.
JAMA Intern Med. 2014;174(8):1263-1270. doi:10.1001/jamainternmed.2014.2266.

Perspective | 
Avery MacKenzie, MD
JAMA Intern Med. 2014;174(8):1221-1222. doi:10.1001/jamainternmed.2014.2124.

Invited Commentary | 
David M. Shahian, MD
JAMA Intern Med. 2014;174(8):1328-1329. doi:10.1001/jamainternmed.2014.155.

Invited Commentary | 
Paul Arthur James, MD
JAMA Intern Med. 2014;174(8):1261-1262. doi:10.1001/jamainternmed.2014.1000.

Invited Commentary | 
Dhruv S. Kazi, MD, MSc, MS; Mark A. Hlatky, MD
JAMA Intern Med. 2014;174(8):1338-1339. doi:10.1001/jamainternmed.2014.1227.

Original Investigation | 
Kathleen Stergiopoulos, MD, PhD; David L. Brown, MD
JAMA Intern Med. 2014;174(8):1330-1338. doi:10.1001/jamainternmed.2014.2368.
Includes: Supplemental Content

Perspective | 
Timothy Sullivan, MD
JAMA Intern Med. 2014;174(8):1219-1220. doi:10.1001/jamainternmed.2014.2299.

Viewpoint | 
Jon D. Duke, MD, MS; Aaron S. Kesselheim, MD, JD
JAMA Intern Med. 2014;174(8):1213-1214. doi:10.1001/jamainternmed.2014.2705.

Evidence to Practice | 
Daniel A. Ollendorf, MPH; Jeffrey A. Tice, MD; Steven D. Pearson, MD, MSc
JAMA Intern Med. 2014;174(7):1170-1171. doi:10.1001/jamainternmed.2014.2151.

Perspective | 
Carla Carnovale, PharmD; Mauro Venegoni, MD; Emilio Clementi, MD, PhD
JAMA Intern Med. 2014;174(7):1031-1032. doi:10.1001/jamainternmed.2014.1427.

Special Communication | 
Nicholas S. Downing, AB; Theresa Cheng, AB; Harlan M. Krumholz, MD, SM; et al.
JAMA Intern Med. 2014;174(7):1176-1182. doi:10.1001/jamainternmed.2014.1371.
Includes: Supplemental Content

Original Investigation | 
Kasia J. Lipska, MD, MHS; Joseph S. Ross, MD; Yun Wang, PhD; et al.
JAMA Intern Med. 2014;174(7):1116-1124. doi:10.1001/jamainternmed.2014.1824.
Includes: Supplemental Content

Perspective | 
Nicholas J. Rohrhoff, MD; Diana B. McNeill, MD; Joel C. Boggan, MD, MPH
JAMA Intern Med. 2014;174(7):1035-1036. doi:10.1001/jamainternmed.2014.1605.

Perspective | 
Anna Strewler, RN; Rebecca Conroy, RN; Helen Kao, MD
JAMA Intern Med. 2014;174(7):1033-1034. doi:10.1001/jamainternmed.2014.1879.

Viewpoint | 
Gurpreet Dhaliwal, MD
JAMA Intern Med. 2014;174(7):1021-1022. doi:10.1001/jamainternmed.2014.2012.

Invited Commentary | 
Jeffrey Brent, MD, PhD
JAMA Intern Med. 2014;174(6):918-919. doi:10.1001/jamainternmed.2014.19.

Invited Commentary | 
June K. Robinson, MD
JAMA Intern Med. 2014;174(6):970-971. doi:10.1001/jamainternmed.2014.157.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA
Viewpoint  | 
Educational Opportunities With Postevent Debriefing
Paul C. Mullan, MD, MPH; David O. Kessler, MD, MSc; Adam Cheng, MD, FRCPC
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.